# Electrolyte Emergencies

## Hyponatremia

### Classification
- **Mild**: 130-134 mEq/L
- **Moderate**: 125-129 mEq/L
- **Severe**: <125 mEq/L

### Diagnostic Algorithm
1. Confirm true hyponatremia (exclude pseudohyponatremia from hyperglycemia or hyperlipidemia). Corrected Na = Measured Na + 1.6 x [(glucose - 100) / 100]
2. Assess serum osmolality: Hypotonic (<280), isotonic (280-295), hypertonic (>295)
3. Assess volume status: Hypovolemic, euvolemic, or hypervolemic
4. Check urine sodium and urine osmolality

### Common Causes by Volume Status
- **Hypovolemic**: GI losses, diuretics (thiazides most common), cerebral salt wasting, adrenal insufficiency
- **Euvolemic**: SIADH (most common cause overall), hypothyroidism, psychogenic polydipsia, medications (SSRIs, carbamazepine, cyclophosphamide)
- **Hypervolemic**: Heart failure, cirrhosis, nephrotic syndrome, advanced kidney disease

### Treatment

**Acute Symptomatic Hyponatremia (seizures, obtundation)**:
- 3% hypertonic saline 100-150 mL IV bolus over 10-20 minutes
- May repeat once or twice if symptoms persist
- Goal: Raise sodium 4-6 mEq/L in first 1-2 hours to improve symptoms

**Correction Rate Limits (CRITICAL)**:
- **Maximum correction: <8 mEq/L in any 24-hour period**
- In patients at high risk for osmotic demyelination syndrome (ODS) -- chronic hyponatremia >48 hours, alcoholism, malnutrition, hypokalemia, liver disease -- limit to <6 mEq/L in 24 hours
- Overcorrection management: Administer DDAVP 1-2 mcg IV every 6-8 hours and/or D5W infusion to lower sodium back down
- Monitor serum sodium every 2-4 hours during active correction

**Chronic Asymptomatic Hyponatremia**:
- Treat underlying cause
- SIADH: Fluid restriction (800-1000 mL/day), salt tablets, loop diuretics; tolvaptan 15 mg daily for refractory cases (monitor Na closely, risk of overcorrection)
- Hypovolemic: Normal saline (caution: rapid correction can occur as ADH suppresses with volume repletion)

## Hyperkalemia

### Classification
- **Mild**: 5.0-5.9 mEq/L
- **Moderate**: 6.0-6.4 mEq/L
- **Severe**: >= 6.5 mEq/L or any level with ECG changes

### ECG Changes (Progressive)
1. Peaked T waves (earliest sign)
2. PR prolongation
3. QRS widening
4. Loss of P waves
5. Sine wave pattern (pre-arrest)
6. Ventricular fibrillation or asystole

### Treatment Protocol

**Step 1 - Cardiac Membrane Stabilization (if ECG changes present)**:
- **Calcium gluconate** 10% 10 mL (1 ampule) IV over 2-3 minutes; may repeat in 5 minutes if persistent ECG changes
- Or calcium chloride 10% 10 mL IV (via central line preferred; more calcium per volume but tissue necrosis risk peripherally)
- Does NOT lower potassium; protects the heart

**Step 2 - Intracellular Shift (Temporizing)**:
- **Regular insulin 10 units IV + dextrose 50% 25g (1 ampule D50) IV**: Onset 15-30 minutes, duration 4-6 hours. Monitor glucose hourly for 4-6 hours; hypoglycemia occurs in 10-20% of patients.
- **Sodium bicarbonate** 50 mEq IV over 5 minutes: Most effective in metabolic acidosis; limited benefit with normal pH
- **Albuterol** 10-20 mg nebulized (4-8x standard dose): Onset 15-30 minutes; additive effect with insulin/dextrose; avoid in cardiac patients (tachycardia)

**Step 3 - Potassium Elimination**:
- **Sodium polystyrene sulfonate (Kayexalate)**: 15-30g PO or 30-50g PR in sorbitol; onset 1-6 hours; each gram binds approximately 1 mEq K+. Risk of intestinal necrosis (rare); avoid in postoperative patients and bowel pathology.
- **Patiromer (Veltassa)**: 8.4g PO daily; better tolerated; onset 7+ hours; not for acute emergencies
- **Sodium zirconium cyclosilicate (Lokelma)**: 10g PO TID for 48 hours (acute), then 5-10g daily; faster onset than patiromer
- **Loop diuretics**: Furosemide 40-80 mg IV if adequate renal function
- **Hemodialysis**: Definitive treatment for severe, refractory hyperkalemia or in oliguric/anuric renal failure

## Hypocalcemia

### Symptomatic Hypocalcemia (Corrected Ca <7.5 mg/dL or Ionized Ca <1.0 mmol/L)
- Symptoms: Perioral numbness, paresthesias, carpopedal spasm, Chvostek sign, Trousseau sign, seizures, QT prolongation, laryngospasm
- **Calcium gluconate** 10% 1-2 ampules (10-20 mL) IV over 10-20 minutes with cardiac monitoring
- Follow with continuous infusion: Calcium gluconate 10% 100 mL (10 ampules) in 1L NS or D5W at 50 mL/hour; titrate to maintain ionized calcium >1.0 mmol/L
- **Correct hypomagnesemia first**: Hypocalcemia is refractory to treatment if Mg is low; administer MgSO4 2g IV over 15 minutes

### Chronic Management
- Oral calcium carbonate 1000-2000 mg elemental calcium daily in divided doses
- Calcitriol 0.25-0.5 mcg BID (active vitamin D)
- Monitor calcium, phosphorus, and 25-OH vitamin D regularly

## Hypomagnesemia

### Clinical Significance
- Often coexists with hypokalemia and hypocalcemia; both are refractory to correction until magnesium is repleted
- Symptoms: Tremor, muscle cramps, cardiac arrhythmias (torsades de pointes), seizures

### Treatment
- **Severe (<1.0 mg/dL) or symptomatic**: MgSO4 1-2g IV over 15-60 minutes, then 4-8g IV infusion over 24 hours
- **Torsades de pointes**: MgSO4 2g IV push over 1-2 minutes
- **Moderate (1.0-1.5 mg/dL)**: MgSO4 1-2g IV over 1 hour; repeat as needed based on levels
- **Mild or chronic**: Magnesium oxide 400-800 mg PO daily (limited absorption); magnesium chloride or magnesium lactate better absorbed
- **Monitoring**: Recheck levels every 6-12 hours during IV repletion; urine magnesium to assess renal wasting
- **Caution**: Reduce dose in renal impairment; monitor patellar reflexes (loss indicates toxicity)
